RedHill Biopharma (RDHL) EBT Margin Growth (5y) (2017 - 2023)
RedHill Biopharma (RDHL) EBT Margin Growth (5y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 294,042.00 |
| Mar 31, 2023 | -63,128.00 |
| Dec 31, 2022 | -145,871.00 |
| Sep 30, 2022 | -93,777.00 |
| Jun 30, 2022 | -328,800.00 |
| Mar 31, 2022 | 23.23 Mn |
| Dec 31, 2021 | -1.03 Mn |
| Dec 31, 2020 | -990,805.00 |
| Jun 30, 2020 | -51.84 Mn |
| Dec 31, 2019 | -39.75 Mn |
| Sep 30, 2019 | 64,697.00 |
| Jun 30, 2019 | 90,362.00 |
| Mar 31, 2019 | -4.82 Bn |
| Dec 31, 2018 | -35.11 Mn |
| Sep 30, 2018 | 9.02 Mn |
| Jun 30, 2018 | 6.30 Mn |
| Dec 31, 2017 | 2.03 Mn |
| Sep 30, 2017 | 5.98 Mn |
| Jun 30, 2017 | -3.39 Mn |